The importance of time‐to‐adjuvant treatment on survival with pancreatic cancer: A systematic review and meta‐analysis

Author:

Sugumar Kavin1ORCID,Hue Jonathan J.1ORCID,De La Serna Solanus2,Rothermel Luke D.1,Ocuin Lee M.3ORCID,Hardacre Jeffrey M.1,Ammori John B.1ORCID,Winter Jordan M.1

Affiliation:

1. Department of Surgery University Hospitals Seidman Cancer Center Cleveland Ohio USA

2. Case Comprehensive Cancer Center Case Western Reserve University School of Medicine Cleveland Ohio USA

3. Department of Surgery, Division of Hepatobiliary Pancreatic Surgery, Atrium Health Charlotte North Carolina USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Cancer Stat Facts. Uterine Cancer. Surveillance Epidemiology and End Results Program [Internet]. 2020.https://seer.cancer.gov/statfacts/html/pancreas.html.

2. Cancer statistics, 2020

3. EUS-guided biliary drainage: A comprehensive review of the literature

4. National Comprehensive Cancer Network Clinical Practice Guidelines in Clinical Oncology. Pancreatic Adenocarcinoma. Version 1.2020 – November 16 2019.Https://Www.Nccn.Org/Professionals/Physician_Gls/Pdf/Pancreatic.Pdf. Accessed March 4 2020.

5. Adjuvant treatment for pancreatic cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3